[go: up one dir, main page]

ITMI20052351A1 - Nuovo uso farmaceutico delle transferrine e composizioni farmaceutiche derivate - Google Patents

Nuovo uso farmaceutico delle transferrine e composizioni farmaceutiche derivate

Info

Publication number
ITMI20052351A1
ITMI20052351A1 IT002351A ITMI20052351A ITMI20052351A1 IT MI20052351 A1 ITMI20052351 A1 IT MI20052351A1 IT 002351 A IT002351 A IT 002351A IT MI20052351 A ITMI20052351 A IT MI20052351A IT MI20052351 A1 ITMI20052351 A1 IT MI20052351A1
Authority
IT
Italy
Prior art keywords
transferrin
derived
new
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
IT002351A
Other languages
English (en)
Inventor
Rosalba Paesano
Piera Valenti
Original Assignee
Microbo Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36950064&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITMI20052351(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Microbo Srl filed Critical Microbo Srl
Priority to IT002351A priority Critical patent/ITMI20052351A1/it
Priority to PL06724054T priority patent/PL1959988T3/pl
Priority to CN2006800459548A priority patent/CN101325965B/zh
Priority to PCT/EP2006/003106 priority patent/WO2007065482A1/en
Priority to EP06724054.9A priority patent/EP1959988B2/en
Priority to ES06724054.9T priority patent/ES2394344T5/es
Priority to DK06724054.9T priority patent/DK1959988T3/da
Priority to US12/085,201 priority patent/US9050323B2/en
Publication of ITMI20052351A1 publication Critical patent/ITMI20052351A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT002351A 2005-12-09 2005-12-09 Nuovo uso farmaceutico delle transferrine e composizioni farmaceutiche derivate ITMI20052351A1 (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT002351A ITMI20052351A1 (it) 2005-12-09 2005-12-09 Nuovo uso farmaceutico delle transferrine e composizioni farmaceutiche derivate
PL06724054T PL1959988T3 (pl) 2005-12-09 2006-04-05 Zastosowanie laktoferyny bydlęcej do leczenia destrukcyjnego zapalenia błony śluzowej
CN2006800459548A CN101325965B (zh) 2005-12-09 2006-04-05 治疗粘膜破坏性炎症的转铁蛋白的应用
PCT/EP2006/003106 WO2007065482A1 (en) 2005-12-09 2006-04-05 Use of transferrins for treating destructive inflammation of mucous membrane
EP06724054.9A EP1959988B2 (en) 2005-12-09 2006-04-05 Use of bovine lactoferrin for treating destructive inflammation of mucous membrane
ES06724054.9T ES2394344T5 (es) 2005-12-09 2006-04-05 Empleo de lactoferrina bovina para tratar la inflamación destructiva de una membrana mucosa
DK06724054.9T DK1959988T3 (da) 2005-12-09 2006-04-05 Anvendelse af bovint lactoferrin til behandling af destruktiv inflammation af slimhinder
US12/085,201 US9050323B2 (en) 2005-12-09 2006-04-05 Methods of treating destructive inflammation of the mucous membranes with lactoferrin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002351A ITMI20052351A1 (it) 2005-12-09 2005-12-09 Nuovo uso farmaceutico delle transferrine e composizioni farmaceutiche derivate

Publications (1)

Publication Number Publication Date
ITMI20052351A1 true ITMI20052351A1 (it) 2007-06-10

Family

ID=36950064

Family Applications (1)

Application Number Title Priority Date Filing Date
IT002351A ITMI20052351A1 (it) 2005-12-09 2005-12-09 Nuovo uso farmaceutico delle transferrine e composizioni farmaceutiche derivate

Country Status (8)

Country Link
US (1) US9050323B2 (it)
EP (1) EP1959988B2 (it)
CN (1) CN101325965B (it)
DK (1) DK1959988T3 (it)
ES (1) ES2394344T5 (it)
IT (1) ITMI20052351A1 (it)
PL (1) PL1959988T3 (it)
WO (1) WO2007065482A1 (it)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180016636A (ko) 2007-07-12 2018-02-14 바스프 에스이 펄라이트 플레이크 기재 간섭 안료
ES2431338T3 (es) * 2008-11-25 2013-11-26 Indena S.P.A. Extractos vegetales para su uso como fitoquímicos
PL2418945T3 (pl) * 2009-04-15 2019-05-31 Bmg Pharma S P A Kompozycje soli mineralnej - kwasu sulfonowego i sposoby ich stosowania
EP3202416A1 (en) * 2010-04-23 2017-08-09 Probiotec Limited Composition comprising lactoferrin and immunoglobulin
IT1406153B1 (it) 2010-12-23 2014-02-14 Microbo Srl Metodi di prevenzione e terapia per parti e nascite pretermine.
CN103160565A (zh) * 2011-12-09 2013-06-19 彩虹天健康科技研究(北京)有限责任公司 Unc-51激酶影响细胞运铁蛋白的胞吞作用
CN102766206A (zh) * 2012-07-02 2012-11-07 北京济福霖生物技术有限公司 一种改善缺铁性贫血的产品及其制备方法
FR2994657A1 (fr) 2012-08-23 2014-02-28 Henri Allain Nouvelles applications et utilisations de la lactoferrine
CN103550760A (zh) * 2013-11-07 2014-02-05 无锡科捷诺生物科技有限责任公司 乳铁蛋白在制备炎症因子偏高肥胖人群贫血药物中的应用
CN104888202A (zh) * 2014-05-22 2015-09-09 闫牧乔 一种治疗扁桃体炎的药物
US10172786B2 (en) * 2014-12-16 2019-01-08 Axim Biotechnologies, Inc. Oral care composition comprising cannabinoids
CN106310234A (zh) * 2016-08-24 2017-01-11 方雅悯 一种牛乳铁蛋白及水解或酶解物在治疗妇科疾病药物中的应用
CN106377768A (zh) * 2016-08-24 2017-02-08 方雅悯 一种慢性咽炎膜剂及其制备方法
RU2625739C1 (ru) * 2016-09-28 2017-07-18 Общество с ограниченной ответственностью Научно-производственное предприятие "Эксорб" Фармакологическая композиция на основе соединений железа
IT201700002411A1 (it) * 2017-01-11 2018-07-11 Bmg Pharma S R L Preparazione farmaceutica per il trattamento dell’ipoferremia e dell’anemia sideropenica
IT201900004599A1 (it) * 2019-03-27 2020-09-27 Microbo Srl Formulazioni topiche orali e/o orali sistemiche contenenti una miscela a base di lattoferrina, più efficace nella captazione del ferro, per la prevenzione e trattamento di varie patologie
CN111166872A (zh) * 2020-02-24 2020-05-19 中国科学院昆明动物研究所 转铁蛋白在制备免疫抑制剂类药物中的应用
IT202000022420A1 (it) * 2020-09-23 2022-03-23 Microbo Srl Formulazioni per somministrazioni topiche mucosali e/o orali sistemiche contenenti una miscela a base di lattoferrina, più efficace nella captazione del ferro, per la prevenzione e trattamento di varie patologie

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198419A (en) * 1989-12-08 1993-03-30 Immuno Japan Inc. Formulated medicines for enhancing the efficacy of beta-lactam antibiotics in prophylaxis and treatment against infectious disease due to pathogenic bacteria
US6066469A (en) * 1990-03-08 2000-05-23 Ferro Dynamics, Inc. Cloning, expression, and uses of human lactoferrin
DE69322896T2 (de) 1992-03-02 1999-05-27 Immuno Japan Inc., Tokio/Tokyo Verwendung von Proteinen der Transferrin/Lactoferrin-Familie zur Stimulation des Immunsystems
JPH06145068A (ja) * 1992-04-02 1994-05-24 Imuno Japan:Kk 生体防御能賦活剤・感染症治療剤・生体防御能賦活性食品
JPH08217693A (ja) 1995-02-17 1996-08-27 Yoshihisa Naito 新規医薬組成物
US20020016289A1 (en) 1995-06-01 2002-02-07 Orla M. Conneely Methods for treatment and prevention of helicobacter pylori infection using lactoferrin
IT1278137B1 (it) * 1995-07-12 1997-11-17 Piera Valenti Utilizzo della lattoferrina per la terapia topica delle infezioni acute o recidivanti causate da "streptococcus pyogenes" o da altri
US5834424A (en) 1995-07-12 1998-11-10 Gambit International Limited Use of lactoferrin for therapy of acute of chronic infectious diseases by the intracellular gram-positive pathogens streptococcus pyogenes and staphylococcus aureus
US5869446A (en) * 1996-07-09 1999-02-09 Gambit International Limited Preparation of lactoferrin (or serotransferrin or ovotransferrin) and desferrioxamine methanesulfonate (or other low molecular weight metal ion chelators) for the therapy of viral infections
EP1017407A2 (en) 1997-02-03 2000-07-12 Pharming Intellectual Property BV Useful properties of human lactoferrin and variants thereof
CA2288982A1 (en) * 1997-05-03 1998-11-12 Board Of Regents, The University Of Texas System Methods for preventing and treating the insult-induced metabolic imbalance in humans and other animals
US6188915B1 (en) † 1998-05-19 2001-02-13 Harris Corporation Bootstrapped, piecewise-asymptotic directivity pattern control mechanism setting weighting coefficients of phased array antenna
EP1068871A1 (en) * 1999-07-07 2001-01-17 Jean-Paul Perraudin Novel methods and medicament for treating infections diseases involving microbial biofilms
AU4486501A (en) * 2000-03-27 2001-10-08 Pharming Intellectual Property Bv High dosage parenteral administration of lactoferrin
JP4683740B2 (ja) 2001-02-15 2011-05-18 明治乳業株式会社 炎症に伴う症状の軽減剤
DE10215315A1 (de) * 2002-04-05 2003-11-20 Aventis Behring Gmbh Intellect Human-Transferrin zur Behandlung der Anaemia of Chronic Disease (ACD) und des funktionellen Eisenmangels
WO2003099207A2 (en) * 2002-05-24 2003-12-04 Agennix Incorporated Oral lactoferrin in the treatment of respiratory disorders
WO2004050037A2 (en) 2002-12-04 2004-06-17 Agennix Incorporated Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease
WO2004052281A2 (en) † 2002-12-06 2004-06-24 Agennix Incorporated Oral lactoferrin in the treatment of sepsis
WO2005018542A2 (en) † 2003-07-10 2005-03-03 Agennix Incorporated Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects

Also Published As

Publication number Publication date
EP1959988A1 (en) 2008-08-27
DK1959988T3 (da) 2012-09-10
US20090156484A1 (en) 2009-06-18
WO2007065482A1 (en) 2007-06-14
US9050323B2 (en) 2015-06-09
CN101325965B (zh) 2012-09-12
CN101325965A (zh) 2008-12-17
PL1959988T3 (pl) 2012-11-30
EP1959988B1 (en) 2012-05-23
ES2394344T3 (es) 2013-01-30
ES2394344T5 (es) 2016-05-05
EP1959988B2 (en) 2016-03-09

Similar Documents

Publication Publication Date Title
ITMI20052351A1 (it) Nuovo uso farmaceutico delle transferrine e composizioni farmaceutiche derivate
LTC1858864I2 (lt) Lakiųjų alkilinimo agentų stabilizuotos kompozicijos ir jų panaudojimo būdai
BRPI0911688A2 (pt) "compostos de pirimidina, composições e métodos de uso"
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
SMT201400181B (it) Composizioni per vasocostrizione e metodi d'uso
BRPI0618904A2 (pt) composto, composição farmacêutica, e, uso do composto
BRPI0818003A2 (pt) inibidores de csf-1r, composições e métodos de uso
BRPI0511900A (pt) composições farmacêuticas
EP1845086A4 (en) N-SUBSTITUTED N-METHOXYCARBAMATES BY 2-SUBSTITUTED PHENYL GROUPS, THEIR SYNTHESIS AND THEIR APPLICATIONS
DK3395339T3 (da) Hurtigt opløsende formulering af cinacalcet-hcl
BRPI0820899A2 (pt) Formulação cosmética, e, uso da composição
BRPI0614205A2 (pt) composto, composição farmacêutica, e, uso de composto
CY2014030I1 (el) Θεραπευτικες συνθεσεις που περιλαμβανουν ingenol-3-angelate
ITMI20050728A1 (it) Formulazione innovativa
PL1861387T3 (pl) Pochodne benzoimidazolu i ich kompozycje farmaceutyczne
DK1931315T3 (da) Depotformuleringer af nalbufin
BRPI0819299A2 (pt) Uso de composição, e, composição contendo proteína
BRPI0821115A2 (pt) Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto
BRPI0816350A2 (pt) Composições orais, produtos e métodos de uso
BRPI0813000A2 (pt) Composições terapêuticas e uso das mesmas
BRPI0821004A2 (pt) Composto derivado de aminopirazol, composição farmacêutica que o contem e uso deste
EP1890677A4 (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USE
BRPI0812159A2 (pt) inibidores de csf-1r, composições e métodos de uso
BRPI0921699A2 (pt) complexo antioxidante, composicoes cosmeticas e farmaceutica contendo o referido complexo e uso deste complexo
ATE551899T1 (de) Feststoff-formulierung fungizider mischungen